Prelude Capital Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,409
| Closed | -$226K | – | 1043 |
|
|
2025
Q1 | $226K | Sell |
2,409
-11,067
| -82% | -$991K | 0.02% | 863 |
|
|
2024
Q4 | $1.23M | Buy |
13,476
+5,236
| +64% | +$500K | 0.08% | 325 |
|
|
2024
Q3 | $855K | Buy |
8,240
+900
| +12% | +$91.7K | 0.05% | 432 |
|
|
2024
Q2 | $712K | Buy |
+7,340
| New | +$677K | 0.05% | 395 |
|
|
2023
Q1 | – | Sell |
-3,500
| Closed | -$276K | – | 1218 |
|
|
2022
Q4 | $276K | Sell |
3,500
-21,064
| -86% | -$1.58M | 0.01% | 823 |
|
|
2022
Q3 | $1.73M | Buy |
24,564
+17,805
| +263% | +$1.4M | 0.06% | 269 |
|
|
2022
Q2 | $542K | Buy |
6,759
+2,472
| +58% | +$193K | 0.02% | 774 |
|
|
2022
Q1 | $325K | Sell |
4,287
-4,266
| -50% | -$338K | 0.01% | 1047 |
|
|
2021
Q4 | $730K | Buy |
8,553
+3,690
| +76% | +$288K | 0.02% | 790 |
|
|
2021
Q3 | $368K | Sell |
4,863
-8,379
| -63% | -$665K | 0.01% | 1039 |
|
|
2021
Q2 | $1.08M | Buy |
+13,242
| New | +$1.08M | 0.03% | 570 |
|
|
2020
Q4 | – | Sell |
-4,935
| Closed | -$408K | – | 1371 |
|
|
2020
Q3 | $381K | Sell |
4,935
-49,564
| -91% | -$3.78M | 0.02% | 498 |
|
|
2020
Q2 | $3.99M | Buy |
54,499
+2,798
| +5% | +$199K | 0.22% | 64 |
|
|
2020
Q1 | $3.43M | Buy |
51,701
+41,130
| +389% | +$2.9M | 0.23% | 54 |
|
|
2019
Q4 | $728K | Buy |
+10,571
| New | +$721K | 0.03% | 471 |
|
|
2019
Q3 | – | Sell |
-330
| Closed | -$24K | – | 1737 |
|
|
2019
Q2 | $24K | Sell |
330
-3,456
| -91% | -$245K | ﹤0.01% | 1259 |
|
|
2019
Q1 | $259K | Sell |
3,786
-16,769
| -82% | -$1.08M | 0.01% | 633 |
|
|
2018
Q4 | $1.22M | Buy |
+20,555
| New | +$1.29M | 0.08% | 271 |
|
|
2017
Q4 | – | Sell |
-6,985
| Closed | -$509K | – | 1392 |
|
|
2017
Q3 | $509K | Buy |
6,985
+469
| +7% | +$33.8K | 0.05% | 373 |
|
|
2017
Q2 | $483K | Buy |
+6,516
| New | +$484K | 0.05% | 336 |
|
|
2017
Q1 | – | Sell |
-1,840
| Closed | -$120K | – | 1526 |
|
|
2016
Q4 | $120K | Buy |
+1,840
| New | +$126K | 0.01% | 764 |
|
|
2016
Q1 | – | Sell |
-210
| Closed | -$14K | – | 1293 |
|
|
2015
Q4 | $14K | Sell |
210
-26,029
| -99% | -$1.73M | ﹤0.01% | 1234 |
|
|
2015
Q3 | $1.67M | Sell |
26,239
-16,943
| -39% | -$1.11M | 0.24% | 99 |
|
|
2015
Q2 | $2.83M | Buy |
+43,182
| New | +$2.93M | 0.4% | 48 |
|
|
2015
Q1 | – | Sell |
-600
| Closed | -$42K | – | 1960 |
|
|
2014
Q4 | $42K | Sell |
600
-2,750
| -82% | -$186K | 0.01% | 1319 |
|
|
2014
Q3 | $218K | Sell |
3,350
-1,300
| -28% | -$85.7K | 0.03% | 681 |
|
|
2014
Q2 | $317K | Sell |
4,650
-1,100
| -19% | -$73.7K | 0.04% | 540 |
|
|
2014
Q1 | $373K | Buy |
5,750
+30
| +0.5% | +$1.89K | 0.05% | 514 |
|
|
2013
Q4 | $373K | Sell |
5,720
-1,400
| -20% | -$89.6K | 0.06% | 450 |
|
|
2013
Q3 | $422K | Hold |
7,120
| – | – | 0.07% | 337 |
|
|
2013
Q2 | $408K | Buy |
+7,120
| New | +$423K | 0.09% | 294 |
|
Other funds holding CL
Prelude Capital Management's CL Position: Q2 2025 in Review
Prelude Capital Management sold out of Colgate-Palmolive (CL) in Q2 2025, closing a stake of 2,409 shares — an estimated $226K sold.
Prelude Capital Management first reported a position in CL in Q2 2013 and held it in 31 quarters. The position peaked at $3.99M in Q2 2020. 1,917 funds tracked by Wall St. Rank hold CL as of Q2 2025.
- Prelude Capital Management reported no remaining Colgate-Palmolive position as of Q2 2025 after selling out during the quarter.
- Prelude Capital Management sold 2,409 Colgate-Palmolive shares in Q2 2025, an estimated $226K.
- Prelude Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and held it in 31 quarters.
- Prelude Capital Management's Colgate-Palmolive position peaked at $3.99M in Q2 2020.
- 1,917 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.
Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.